Alvotech and Dr. Reddy’s gets FDA nod for Biologic License Application for AVT03
Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. FDA has accepted a Biologic License Application submission for AVT03. Read more here.
MPR2h
FDA Approves Losartan Oral Suspension Arbli
The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
AllAfrica on MSN11h
Nigeria: How Mohbad Died, Auxiliary Nurse Ogedengbe Reveals
Auxiliary nurse Feyisayo Ogedengbe, who administered a tetanus injection to late singer Ilerioluwa 'Mohbad' Aloba, has narrated how he died. On 6 October 2023, PREMIUM TIMES reported that the police ...